title: Human hexokinase II gene: exon-intron organization, mutation screening in NIDDM, and its relationship to muscle hexokinase activity.
abstract: In muscle, hexokinase II (HK2) regulates phosphorylation of glucose to glucose 6-phosphate, which has been reported to be impaired in patients with non-insulin-dependent diabetes mellitus (NIDDM). Here we report decreased HK2 enzyme activity in skeletal muscle biopsies from patients with impaired glucose tolerance compared with healthy control subjects (2.7 +/- 0.9 vs 4.9 +/- 1.1 nmol.min-1.mg protein-1). Therefore, mutations in the HK2 gene could contribute to skeletal muscle insulin resistance in NIDDM. To address this question, we first determined the exon-intron structure of the human HK2 gene and using this information, we screened all 18 exons with single-strand conformation polymorphism technique in 80 Finnish NIDDM patients. Nine nucleotide substitutions were found, one of which was a missense mutation (Gln142-His142) in exon 4. In human muscle, a single HK2 mRNA transcript with a size of approximately 5500 nucleotides was detected with Northern blot analysis. We also describe an HK2 pseudogene (HK2P1), which was mapped to chromosome 4, band q26, by fluorescence in situ hybridization to metaphase chromosomes. The clinical characteristics and HK2 enzyme activities of the subjects with either Gln or His at residue 142 did not differ from each other. Instead, HK2 activity correlated inversely with fasting blood glucose levels, suggesting that changes in HK2 activity could be secondary to other metabolic abnormalities (r = 0.55; p < 0.0003; n = 39). In conclusion; the data suggest that impaired HK2 activity in prediabetic individuals is a consequence of impaired glucose tolerance rather than of a genetic abnormality. The data thus seem to rule out mutations in the HK2 gene as a major cause of inherited insulin resistance in NIDDM.
authors.affiliation: Department of Biochemistry, University of Helsinki, Finland.
authors.forename: M
authors.initials: M
authors.lastname: Lehto
authors.forename: X
authors.initials: X
authors.lastname: Huang
authors.forename: E M
authors.initials: EM
authors.lastname: Davis
authors.forename: M M
authors.initials: MM
authors.lastname: Le Beau
authors.forename: E
authors.initials: E
authors.lastname: Laurila
authors.forename: K F
authors.initials: KF
authors.lastname: Eriksson
authors.forename: G I
authors.initials: GI
authors.lastname: Bell
authors.forename: L
authors.initials: L
authors.lastname: Groop
mesh_terms: D000368:Aged; D001483:Base Sequence; D004252:DNA Mutational Analysis; D017931:DNA Primers; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000201:enzymology* / Q000235:genetics*; D005091:Exons; D005260:Female; D006593:Hexokinase / Q000235:genetics*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007333:Insulin Resistance; D007438:Introns; D007527:Isoenzymes / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D018482:Muscle, Skeletal / Q000201:enzymology*; D009154:Mutation; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D018807:Polymorphism, Single-Stranded Conformational; D011544:Pseudogenes; D015183:Restriction Mapping
chemical_list: D017931:DNA Primers; D007527:Isoenzymes; D006593:Hexokinase